Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab

Novartis Pharmaceuticals · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
adultmsmultiple-sclerosis
relapsing multiple sclerosis, rms, ms, multiple sclerosis, omb157, adult, secondary progressive ms, spms, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 887326
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.